{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T03:06:17Z","timestamp":1782529577694,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.bcp.2021.114420","type":"journal-article","created":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T21:07:47Z","timestamp":1610831267000},"page":"114420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Prenatal dexamethasone exposure induces nonalcoholic fatty liver disease in male rat offspring via the miR-122\/YY1\/ACE2-MAS1 pathway"],"prefix":"10.1016","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9268-4520","authenticated-orcid":false,"given":"Heze","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongguo","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2021.114420_b0005","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2021.114420_b0010","doi-asserted-by":"crossref","unstructured":"Crowther CA, McKinlay CJ, Middleton P, Harding JE (2015) Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. The Cochrane database of systematic reviews (7):CD003935. doi:10.1002\/14651858.CD003935.pub4.","DOI":"10.1002\/14651858.CD003935.pub4"},{"issue":"17","key":"10.1016\/j.bcp.2021.114420_b0015","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1056\/NEJMe058187","article-title":"Developmental origins of health and disease","volume":"353","author":"Gillman","year":"2005","journal-title":"New England J. Med."},{"issue":"3","key":"10.1016\/j.bcp.2021.114420_b0020","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3390\/ijms17030369","article-title":"Postnatal high-fat diet increases liver steatosis and apoptosis threatened by prenatal dexamethasone through the oxidative effect","volume":"17","author":"Huang","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2021.114420_b0025","first-page":"917","article-title":"Melatonin alleviates liver steatosis induced by prenatal dexamethasone exposure and postnatal high-fat diet","volume":"16","author":"Tsai","year":"2018","journal-title":"Experim. Therapeutic Medicine"},{"key":"10.1016\/j.bcp.2021.114420_b0030","doi-asserted-by":"crossref","unstructured":"Haemmerle G, Lass A, Zimmermann R, Gorkiewicz G, Meyer C, Rozman J, Heldmaier G, Maier R, Theussl C, Eder S, Kratky D, Wagner EF, Klingenspor M, Hoefler G, Zechner R (2006) Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 312 (5774):734-737. doi:10.1126\/science.1123965.","DOI":"10.1126\/science.1123965"},{"key":"10.1016\/j.bcp.2021.114420_b0035","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1016\/j.ajog.2008.05.022","article-title":"Down-regulation of transcription factor peroxisome proliferator-activated receptor in programmed hepatic lipid dysregulation and inflammation in intrauterine growth-restricted offspring","volume":"199","author":"Magee","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114420_b0040","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tem.2007.10.009","article-title":"SREBPs: the crossroads of physiological and pathological lipid homeostasis","volume":"19","author":"Raghow","year":"2008","journal-title":"Trends Endocrinol. Metab.: TEM"},{"issue":"6","key":"10.1016\/j.bcp.2021.114420_b0045","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jhep.2009.12.033","article-title":"Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model","volume":"52","author":"Shindo","year":"2010","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114420_b0050","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1172\/JCI34275","article-title":"Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice","volume":"118","author":"Postic","year":"2008","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.bcp.2021.114420_b0055","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.taap.2007.06.018","article-title":"Differential gene expression and lipid metabolism in fatty liver induced by acute ethanol treatment in mice","volume":"223","author":"Yin","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2021.114420_b0060","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.2337\/db15-1637","article-title":"Hepatic ATF6 increases fatty acid oxidation to attenuate hepatic steatosis in mice through peroxisome proliferator-activated receptor alpha","volume":"65","author":"Chen","year":"2016","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.bcp.2021.114420_b0065","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1194\/jlr.M800614-JLR200","article-title":"Hepatic triacylglycerol hydrolysis regulates peroxisome proliferator-activated receptor alpha activity","volume":"50","author":"Sapiro","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bcp.2021.114420_b0070","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fphys.2015.00117","article-title":"Role of non-classical renin-angiotensin system axis in renal fibrosis","volume":"6","author":"Lv","year":"2015","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bcp.2021.114420_b0075","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fendo.2013.00201","article-title":"Update on the Angiotensin converting enzyme 2-Angiotensin (1\u20137)-MAS receptor axis: fetal programing, sex differences, and intracellular pathways","volume":"4","author":"Chappell","year":"2014","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114420_b0080","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1042\/CS20171550","article-title":"Fetal programming and the angiotensin-(1\u20137) axis: a review of the experimental and clinical data","volume":"133","author":"South","year":"2019","journal-title":"Clin. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2021.114420_b0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1538\/expanim.17-0053","article-title":"Loss of angiotensin converting enzyme II (ACE2) accelerates the development of liver injury induced by thioacetamide","volume":"67","author":"Wu","year":"2018","journal-title":"Exp. Anim."},{"issue":"9","key":"10.1016\/j.bcp.2021.114420_b0090","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/mt.2015.92","article-title":"ACE2 therapy using adeno-associated viral vector inhibits liver fibrosis in mice","volume":"23","author":"Mak","year":"2015","journal-title":"Mol Ther"},{"issue":"4","key":"10.1016\/j.bcp.2021.114420_b0095","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3123","article-title":"Angiotensin-converting enzyme 2 inhibits endoplasmic reticulum stress-associated pathway to preserve nonalcoholic fatty liver disease","volume":"35","author":"Cao","year":"2019","journal-title":"Diabetes\/Metab. Res. Reviews"},{"issue":"4","key":"10.1016\/j.bcp.2021.114420_b0100","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/bfgp\/elz002","article-title":"Interplay between miRNAs and host genes and their role in cancer","volume":"18","author":"Liu","year":"2019","journal-title":"Brief Funct. Genom."},{"issue":"10","key":"10.1016\/j.bcp.2021.114420_b0105","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s00125-019-4951-9","article-title":"Intrauterine programming of obesity and type 2 diabetes","volume":"62","author":"Fernandez-Twinn","year":"2019","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.bcp.2021.114420_b0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.apsb.2015.01.002","article-title":"Emerging role of microRNAs in lipid metabolism","volume":"5","author":"Yang","year":"2015","journal-title":"Acta pharmaceut. Sin. B"},{"key":"10.1016\/j.bcp.2021.114420_b0115","first-page":"844","article-title":"Her GM (2018) Liver-directed microRNA-7a depletion induces nonalcoholic fatty liver disease by stabilizing YY1-mediated lipogenic pathways in zebrafish","volume":"8","author":"Lai","year":"1863","journal-title":"Biochim. Biophys. Acta, Mol. Cell. Biol. Lipids"},{"issue":"4","key":"10.1016\/j.bcp.2021.114420_b0120","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1159\/000485765","article-title":"MicroRNA-122 inhibits lipid droplet formation and hepatic triglyceride accumulation via Yin Yang 1","volume":"44","author":"Wu","year":"2017","journal-title":"Cellular Physiol. Biochem."},{"key":"10.1016\/j.bcp.2021.114420_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.114979","article-title":"miR-148a\/LDLR mediates hypercholesterolemia induced by prenatal dexamethasone exposure in male offspring rats","volume":"395","author":"Li","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114420_b0130","doi-asserted-by":"crossref","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ, Clin NS (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (6):1313-1321. doi:10.1002\/hep.20701.","DOI":"10.1002\/hep.20701"},{"key":"10.1016\/j.bcp.2021.114420_b0135","doi-asserted-by":"crossref","unstructured":"Kumar A, Kumar V, Rattan V, Jha V, Pal A, Bhattacharyya S (2017) Molecular spectrum of secretome regulates the relative hepatogenic potential of mesenchymal stem cells from bone marrow and dental tissue. Scientific reports 7. doi:ARTN 15015 10.1038\/s41598-017-14358-0.","DOI":"10.1038\/s41598-017-14358-0"},{"key":"10.1016\/j.bcp.2021.114420_b0140","doi-asserted-by":"crossref","unstructured":"John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS (2004) Human MicroRNA targets. Plos Biol 2 (11):1862-1879. doi:ARTN e36310.1371\/journal.pbio.0020363.","DOI":"10.1371\/journal.pbio.0020363"},{"issue":"7","key":"10.1016\/j.bcp.2021.114420_b0145","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0092-8674(03)01018-3","article-title":"Prediction of mammalian microRNA targets","volume":"115","author":"Lewis","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2021.114420_b0150","unstructured":"Chum PY, Haas A, Kelley M, Lafayette CO Solution for RT-qPCR: relative gene expression analysis using Thermo Scientific PikoReal Real-Time PCR System and Solaris gene expression reagents. Target."},{"key":"10.1016\/j.bcp.2021.114420_b0155","doi-asserted-by":"crossref","unstructured":"Sandelin A, Alkema W, Engstrom P, Wasserman WW, Lenhard B (2004) JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res 32:D91-D94. doi:10.1093\/nar\/gkh012.","DOI":"10.1093\/nar\/gkh012"},{"key":"10.1016\/j.bcp.2021.114420_b0160","doi-asserted-by":"crossref","unstructured":"Rew Y, Du X, Eksterowicz J, Zhou H, Jahchan N, Zhu L, Yan X, Kawai H, McGee LR, Medina JC, Huang T, Chen C, Zavorotinskaya T, Sutimantanapi D, Waszczuk J, Jackson E, Huang E, Ye Q, Fantin VR, Sun D (2018) Discovery of a potent and selective steroidal glucocorticoid receptor antagonist (ORIC-101). Journal of medicinal chemistry. doi:10.1021\/acs.jmedchem.8b00743.","DOI":"10.1021\/acs.jmedchem.8b00743"},{"key":"10.1016\/j.bcp.2021.114420_b0165","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-2393-13-104","article-title":"Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol","volume":"13","author":"Crowther","year":"2013","journal-title":"BMC Pregnancy Childbirth"},{"issue":"5 Pt 1","key":"10.1016\/j.bcp.2021.114420_b0170","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0029-7844(02)02023-9","article-title":"ACOG committee opnion: antenatal corticosteroid therapy for fetal maturation","volume":"99","author":"Committee on Obstetric P","year":"2002","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.bcp.2021.114420_b0175","doi-asserted-by":"crossref","unstructured":"Haram K, Mortensen JH, Magann EF, Morrison JC (2017) Antenatal corticosteroid treatment: factors other than lung maturation. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet 30 (12):1437-1441. doi:10.1080\/14767058.2016.1219716.","DOI":"10.1080\/14767058.2016.1219716"},{"issue":"9","key":"10.1016\/j.bcp.2021.114420_b0180","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1471-0528.1999.tb08440.x","article-title":"Are we prescribing multiple courses of antenatal corticosteroids? A survey of practice in the UK","volume":"106","author":"Brocklehurst","year":"1999","journal-title":"Br. J. Obstet. Gynaecol."},{"issue":"7","key":"10.1016\/j.bcp.2021.114420_b0185","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1210\/en.2002-0145","article-title":"Glucocorticoids and sex-dependent development of brain glucocorticoid and mineralocorticoid receptors","volume":"144","author":"Owen","year":"2003","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.bcp.2021.114420_b0190","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1111\/jog.12466","article-title":"Effects of a single course versus repeated courses of antenatal corticosteroids on fetal growth, placental morphometry and the differential regulation of vascular endothelial growth factor","volume":"40","author":"Elfayomy","year":"2014","journal-title":"J. Obstetrics Gynaecol. Res."},{"issue":"7","key":"10.1016\/j.bcp.2021.114420_b0195","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrendo.2014.73","article-title":"Glucocorticoids and fetal programming part 1: Outcomes","volume":"10","author":"Moisiadis","year":"2014","journal-title":"Nature Rev. Endocrinol."},{"key":"10.1016\/j.bcp.2021.114420_b0200","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tox.2019.02.008","article-title":"Prenatal caffeine exposure increases the susceptibility to non-alcoholic fatty liver disease in female offspring rats via activation of GR-C\/EBPalpha-SIRT1 pathway","volume":"417","author":"Hu","year":"2019","journal-title":"Toxicology"},{"issue":"3","key":"10.1016\/j.bcp.2021.114420_b0205","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.toxlet.2013.11.006","article-title":"Intrauterine metabolic programming alteration increased susceptibility to non-alcoholic adult fatty liver disease in prenatal caffeine-exposed rat offspring","volume":"224","author":"Wang","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bcp.2021.114420_b0210","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/296537","article-title":"Altered hepatic lipid metabolism contributes to nonalcoholic fatty liver disease in leptin-deficient Ob\/Ob mice","volume":"2013","author":"Perfield","year":"2013","journal-title":"J. Obesity"},{"key":"10.1016\/j.bcp.2021.114420_b0215","doi-asserted-by":"crossref","unstructured":"Sun T, Gao F, Li X, Cai Y, Bai M, Li F, Du L (2018) A combination of ultrasound-targeted microbubble destruction with transplantation of bone marrow mesenchymal stem cells promotes recovery of acute liver injury. Stem cell research & therapy 9 (1):356. doi:10.1186\/s13287-018-1098-4.","DOI":"10.1186\/s13287-018-1098-4"},{"issue":"11","key":"10.1016\/j.bcp.2021.114420_b0220","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s11655-017-2909-7","article-title":"Balancing effect of biejiajian oral liquid on ACE-Ang II-AT1R Axis and ACE2-Ang-(1\u20137)-Mas axis in rats with CCl4-induced hepatic fibrosis","volume":"24","author":"Li","year":"2018","journal-title":"Chin. J. Integr. Med."},{"issue":"6","key":"10.1016\/j.bcp.2021.114420_b0225","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41440-018-0040-6","article-title":"The role of the angiotensin II type I receptor blocker telmisartan in the treatment of non-alcoholic fatty liver disease: a brief review","volume":"41","author":"Borem","year":"2018","journal-title":"Hypertension Res."},{"key":"10.1016\/j.bcp.2021.114420_b0230","doi-asserted-by":"crossref","first-page":"21592","DOI":"10.1038\/srep21592","article-title":"Angiotensin-converting enzyme 2\/angiotensin-(1\u20137)\/Mas axis activates Akt signaling to ameliorate hepatic steatosis","volume":"6","author":"Cao","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2021.114420_b0235","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/gutjnl-2012-303150","article-title":"Yin Yang 1 promotes hepatic steatosis through repression of farnesoid X receptor in obese mice","volume":"63","author":"Lu","year":"2014","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.bcp.2021.114420_b0240","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1051\/medsci\/20163201004","article-title":"Developmental origin of health and adult diseases (DOHaD): evolution of a concept over three decades","volume":"32","author":"Charles","year":"2016","journal-title":"Medecine Sciences: M\/S"},{"key":"10.1016\/j.bcp.2021.114420_b0245","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000439488","article-title":"Development, epigenetics and metabolic programming","volume":"85","author":"Godfrey","year":"2016","journal-title":"Nestle Nutrition Institute workshop series"},{"issue":"4","key":"10.1016\/j.bcp.2021.114420_b0250","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.clp.2014.08.006","article-title":"Fetal programming, epigenetics, and adult onset disease","volume":"41","author":"Lane","year":"2014","journal-title":"Clin. Perinatol."},{"key":"10.1016\/j.bcp.2021.114420_b0255","doi-asserted-by":"crossref","unstructured":"Martino F, Magenta A, Pannarale G, Martino E, Zanoni C, Perla FM, Puddu PE, Barilla F (2016) Epigenetics and cardiovascular risk in childhood. Journal of cardiovascular medicine 17 (8):539-546. doi:10.2459\/JCM.0000000000000334.","DOI":"10.2459\/JCM.0000000000000334"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221000162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221000162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:22:50Z","timestamp":1757769770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221000162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":51,"alternative-id":["S0006295221000162"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114420","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prenatal dexamethasone exposure induces nonalcoholic fatty liver disease in male rat offspring via the miR-122\/YY1\/ACE2-MAS1 pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114420","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114420"}}